ENTITY
Consun Pharmaceutical

Consun Pharmaceutical (1681 HK)

59
Analysis
Health Care • China
Consun Pharmaceutical Group is a modern pharmaceutical enterprise engaged in the research, development, production, and marketing of modern Chinese medicines and medical imaging contrast mediums. It also manufactures and sells traditional Chinese medicines. Key products include Uremic Clearance Granule for kidney disease, Gadopentetate Dimeglumine Injection as a medical contrast medium, and Iron Dextran Oral Solution. The company was founded in 1997 and is headquartered in Guangzhou, China.
more
bullish•Quantitative Analysis
•20 Jan 2020 09:33

Hong Kong Buyback Weekly: Xingyi Glass, Yichang HEC, Consun Pharma

Hong Kong Exchange publishes share repurchases by listed companies on a daily basis. In our weekly note, we will provide statistics on top...

Logo
489 Views
Share
bullish•Kingsoft
•03 Jun 2019 14:05

HK Connect Snippet: Auto Manufacturers, Kingsoft (2019-05-31)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
764 Views
Share
bullish•China Tower
•14 Jan 2019 14:50

HK Connect Discovery Weekly: China Tower, Tencent, New China Life (2019-01-11)

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
714 Views
Share
bullish•Great Wall Motor
•09 Jan 2019 09:55

HK Connect Discovery Weekly: CR Beer, Great Wall Motors, and Kingsoft (2019-01-07)

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
845 Views
Share
bullish•BYD Electronic
•03 Dec 2018 14:48

Discover HK Connect: What Mainlanders Are Buying (2018-12-03)

With the implementation of Hong Kong Connect in 2014, mainland Chinese investors could access the international market on the Hong Kong Stock...

Logo
605 Views
Share
x